AstraZeneca’s Imfinzi Gets Expanded EU Label With Approval for Gastric Cancer

3 months ago 75

The EU support of Imfinzi for early-stage gastric and gastroesophageal cancers expands the statement of 1 of the company’s top-selling oncology medicines.

Read Entire Article

AstraZeneca’s Imfinzi Gets Expanded EU Label With Approval for Gastric Cancer

Related

Can a Prettier Data Center Curb the Community Backlash?

Intel’s Insiders

Pricier iPhones Are Coming. What—and When—Should You Buy?

Popular

Farnham backs public ownership of golf course site

Mink numbers to be cut by 90% in Kent

Clusters of Severe Stomach Illness Reported Across the U.S.

Rolling Stones, deadites and pioneers: What to see, do or he...

Heat waves are taking a big toll on chickens